Recent progress in understanding the neuroprotective mechanism of carnosic acid in Parkinson's disease

doi:10.12092/j.issn.1009-2501.2023.09.015

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (9): 1073-1080.doi: 10.12092/j.issn.1009-2501.2023.09.015

Previous Articles Next Articles

Recent progress in understanding the neuroprotective mechanism of carnosic acid in Parkinson's disease

WANG Jingang1, LI Qiang1, SUN Huiyan2,WANG Hongquan3

1The Affiliated Hospital of Chifeng University, Chifeng 024000, Inner Mongolia, China; 2Chifeng University Health Science Center, Chifeng 024000, Inner Mongolia, China; 3Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China

Received:2023-05-15 Revised:2023-07-10 Online:2023-09-26 Published:2023-09-25

Abstract

Abstract: Carnosic acid (CA) is a natural phenolic diterpene compound found in rosemary (Rosmarinus officinalis) characterized as an ortho-dihydroquinone-type molecule.Multiple lines of studies have shown that CA has potent neuroprotective effects in vitro and in vivo in Parkinson's disease (PD). The aim of the present review is to summarize the pharmacological neuroprotective actions of CA, and provide a comprehensive review of the molecular mechanism by which CA exert neuroprotective effect in PD. The current review highlights CA is a therapeutic potential for PD.

Key words: carnosic acid, rosemary, Parkinson's disease, neuroprotection

CLC Number:

R741.05

WANG Jingang, LI Qiang, SUN Huiyan, WANG Hongquan. Recent progress in understanding the neuroprotective mechanism of carnosic acid in Parkinson's disease[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1073-1080.

[1]	WANG Kun, XU Peipei, ZHOU Lanlan, LU Sheng. Mechanism of neuroprotective effect of ginsenoside Rg1 regulating Epac1/Rap1 signaling pathway in rats with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 721-727.
[2]	LIU Xiaoyan, TIAN Ye, LIU Jifei, SU Gang, ZHANG Zhenchang. Research progress on the protective mechanisms of curcumin on cerebral ischemia-reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1305-1309.
[3]	CAO Shan, ZHOU Gan, PENG Xiang-dong, YANG Guo-ping, ZHOU Hong-hao. Role of Nrf2 in neuroprotection and its mechanisms [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(6): 696-704.
[4]	HE Chun-hui, ZHAO Yi-qing, LI Xia, ZHOU Lu-yao. Research progress in molecular mechanism of the pharmacological actions of leonurine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(12): 1419-1423.
[5]	YE Yi-lu, ZHANG Qi, YU Yue-ping. Phosphodiesterase 3: new targets for drug development [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(6): 711-715.
[6]	YU Yue-ping, YE Yi-lu. Recent progress in research of protective effects of erythropoietin on cerebral ischemia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(6): 609-613.
[7]	HU Jun, HU Gang, WU Jie. Neuronal nicotinic acetylcholine receptor-mediated Ca²⁺ signals and regulation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(4): 361-365.
[8]	YU Yue-ping, XU Qiu-qin, WEI Er-qing. Recent progress in research of neuroprotective drugs on acute ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(8): 841-845.

Recent progress in understanding the neuroprotective mechanism of carnosic acid in Parkinson's disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 8

Recommended Articles 0

Metrics

Comments